Selenium‐Based Molecules to Treat Alzheimer’s Disease

This study led to the identification of novel selenium-based small molecules (N-benzylphenoselenazines) that are able to reduce Aβ40 aggregation and demonstrate antioxidant activity suggesting their potential application as disease-modifying agents to treat AD.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70859_103404
Primary Topic
Organoselenium and organotellurium chemistry
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Selenium‐Based Molecules to Treat Alzheimer’s Disease

Arash Shakeri, Rahul C Karuturi, Ahmed Abdallah Hefny, Praveen Nekkar Rao
Alzheimer s & Dementia
Organoselenium and organotellurium chemistry
article

Selenium‐Based Molecules to Treat Alzheimer’s Disease

Arash Shakeri, Rahul C Karuturi, Ahmed Abdallah Hefny, Praveen Nekkar Rao
article en

Abstract

This study led to the identification of novel selenium-based small molecules (N-benzylphenoselenazines) that are able to reduce Aβ40 aggregation and demonstrate antioxidant activity suggesting their potential application as disease-modifying agents to treat AD.

Alzheimer s & DementiaVol. 21(S5)
University of Waterloo (CA)
Openalex Percentile: Top 33%
Organoselenium and organotellurium chemistry
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Selenium‐Based Molecules to Treat Alzheimer’s Disease — Arash Shakeri, Rahul C Karuturi, et al. · Alzheimer s & Dementia (2025) | TGRS Research Map | TGRS